113 - Late Breaker I - COVID 19 Update

Co-Author(s)

• MB

  Meghan Baker, MD, ScD

  Associate Hospital Epidemiologist
  Brigham and Women's Hospital
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Michael Klompas, MD, MPH

  Professor
  Harvard Medical School and Harvard Pilgrim Health Care Institute
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LL

  Lucía Luna Wong, PhD

  4th year Medical Student
  Wayne State University School of Medicine
  Detroit, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CM

  Charles Morris, n/a

  Associate Chief Medical Officer
  Brigham and Women's Hospital
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• IO

  Ijeoma Opara, MD

  Dr.
  Internal Medicine
  Wayne State University
  Detroit, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DQ

  Daniel Quan, BS

  Medical Student
  Wayne State University School of Medicine
  Detroit, Michigan

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AR

  Andrew Resnick, MD, MBA

  Chief Quality and Safety Officer
  Department of Quality and Safety
  Brigham and Women's Hospital
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RT

  Robert Tucker, MPH

  Manager, Infection Prevention and Control
  Brigham and Women's Hospital
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• VV

  Vineeta Vaidya, MS

  Infection Preventionist
  Brigham and Women's Hospital
  Boston, Massachusetts

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MZ

  Marcus Zervos, MD

  Infectious Disease Division Head
  Henry Ford Health System
  Detroit, Michigan

  Disclosure: Melinta Therapeutics (Grant/Research Support)

Presenting Author(s)

• 

  Chanu Rhee, MD, MPH

  Assistant Professor
  Population Medicine
  Harvard Medical School
  Boston, MA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Anita Shallal, MD

  Infectious Diseases Fellow
  Henry Ford Hospital
  Detroit, MI

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Speaker(s)

• 

  Deblina Datta, MD, FIDSA

  Clinical Team Lead, HSWS Task Force, CDC COVID -19 Response
  US Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides
• PM

  Peter Marks

  Food & Drug Administration

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• describe COVID-19 infection and effect on patients beyond acute illness
• explain the latest update from the FDA on current status of COVID-19 vaccines

Presentations:

• 4:15pm – 5:30pm EDT

  median Income is Associated with Need for Mechanical Ventilation in COVID-19
  Anita Shallal, MD – Henry Ford Hospital; Daniel Quan, BS – Wayne State University School of Medicine; Lucía Luna Wong, PhD – Wayne State University School of Medicine; Ijeoma N. Opara, MD – Wayne State University; Marcus Zervos, MD – Henry Ford Health System
• 4:15pm – 5:30pm EDT

  incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large U.S. Academic Medical Center
  Chanu Rhee, MD, MPH – Harvard Medical School; Meghan Baker, MD, ScD – Brigham and Women's Hospital; Vineeta Vaidya, MS – Brigham and Women's Hospital; Robert Tucker, MPH – Brigham and Women's Hospital; Andrew S. Resnick, MD, MBA – Brigham and Women's Hospital; Charles Morris, n/a – Brigham and Women's Hospital; Michael Klompas, MD, MPH – Harvard Medical School and Harvard Pilgrim Health Care Institute
• 4:15pm – 5:30pm EDT

  A Framework and Timeline of the Clinical Spectrum of Disease due to SARS CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications
  Deblina Datta, MD, FIDSA – US Centers for Disease Control and Prevention
• 4:15pm – 5:30pm EDT

  COVID-19 Vaccine FDA Update
  Peter Marks – Food & Drug Administration